Adjuvant chemotherapy in renal leiomyosarcoma.
Our encounter with a patient with renal leiomyosarcoma prompted a survey of the world literature in which 84 cases were found. The use of chemotherapy after nephrectomy is advocated since our patient survived more than four years without metastases. The rationale for our chemotherapeutic protocol is discussed.
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D003609:Dactinomycin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D007890:Leiomyosarcoma / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D008297:Male; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide